TaskUs delivered a positive third quarter as the market reacted favorably to strong revenue growth and improved profitability ...
Alnylam Pharmaceuticals has seen its Fair Value Estimate rise from $467.94 to $480.17, reflecting a modestly stronger outlook supported by recent analyst enthusiasm. This updated assessment comes ...
Following the strategic review, the Board of Directors of Stora Enso has decided to initiate preparations for the separation of the Swedish forest assets business of Stora Enso into a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback